Skip to content

Interventional study on compliance with inhaled medication treatment in patients with chronic obstructive pulmonary disease assisted by mobile health technology

Interventional study on compliance with inhaled medication treatment in patients with chronic obstructive pulmonary disease assisted by mobile health technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096314
Enrollment
Unknown
Registered
2025-01-21
Start date
2023-03-09
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Experiment Group:Mobile Health Technology Assisted Inhalation Drug Management

Sponsors

Beijing Chaoyang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The diagnosis of chronic obstructive pulmonary disease complies with the disease diagnosis and treatment guidelines formulated by the Respiratory Disease Branch of the Chinese Medical Association; 2. Disease duration <= 1 year; 3. Assessment of medication compliance<6 points; 4. Patients have communication skills and can independently or with the assistance of researchers fill out the required research questionnaire; 5. Have used at least one dry powder inhaler in the past (such as salmeterol, fluticasone powder, budesonide, formoterol powder, tiotropium bromide powder, etc.); 6. Non solitary patients; 7. Having a smartphone, able to access the internet and use apps on the phone; 8. Patient and his/her caregiver agree to cooperate with the relevant requirements of the research plan and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Suffering from diseases such as bronchial asthma, bronchiectasis, tuberculosis damaged lungs, and thoracic deformities; 2. Individuals with severe mental illness or intellectual disability; 3. Individuals with unclear consciousness or communication barriers; 4. Those who do not agree to cooperate with the research or request termination; 5. Patients who participated in other studies that affected the implementation and accuracy of the results of this study.

Design outcomes

Primary

MeasureTime frame
Qualified compliance rate for inhalation drug therapy;

Secondary

MeasureTime frame
Acute exacerbation rate of chronic obstructive pulmonary disease;Changes in cardiopulmonary function;Respiratory Difficulty Scale Score;Disease control evaluation;

Countries

China

Contacts

Public ContactJia Yanrui

Beijing Chaoyang Hospital Affiliated to Capital Medical University

13910707075@139.com+86 139 1070 7075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026